$0.75
24.79%
Nasdaq, Nov 13, 09:49 am EST. Closed.
ISIN
US9186401033
Symbol
VCNX
Reports
Quarter | Annual
Index
NASDAQ Composite
Sector
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology

Vaccinex, Inc. Stock News

Neutral
Vaccinex, Inc.
●
GlobeNewsWire
●
about one month ago
SEMA4D Blockade Reshapes the Tumor Immune Environment in Neoadjuvant Melanoma Study
ROCHESTER, N.Y., Oct. 07, 2026 (GLOBE NEWSWIRE) -- Vaccinex, Inc. a clinical-stage biotechnology company pioneering a differentiated approach to treating Cancer and Alzheimer's disease (AD) through the inhibition of Semaphorin 4D (SEMA4D), today announced the  publication in Nature Communications of results from an Emory University and Winship Cancer Institute-sponsored pilot study evaluating p...

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now
The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today